For citations:
Zhuravleva M.V., Tereshchenko S.N., Zhirov I.V., Villevalde S.V., Marin T.V., Gagarina Yu.V. Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure. Russian Journal of Cardiology. 2021;26(12):4800. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4800
Email this article 